genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Mitral Valve Prolapse Caused by Cilia Defects
News
Liquid Biopsies May Simplify Checkups of Transplanted Stem Cells
News
Taking Brakes off Bad Fat to Good Fat Conversion Could Lead…
News
Ground Control to Major Microbe: New Method IDs Bacteria in Space
News
He Jiankui Research Prompts U.S. Academies, U.K. Society to Create Germline…
Insights
Insights
NIH Solicits Research into Vaccines to Protect against Opioid Use
Neuroscience
Human-Derived Brain Models
Artificial Intelligence
Hey Google. Is This Lung Cancer?
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
Tech Exclusives
Rising to the Challenge of Intensifying Bioprocesses
A-Lists
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
A-Lists
Top 10 Under 40 of 2019
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Insights
Top 10 Sequencing Companies
May 2019 Vol. 39 No. 5
Top 10 Immuno-Oncology Collaborations
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Liquid Biopsies May Simplify Checkups of Transplanted Stem Cells
News
Taking Brakes off Bad Fat to Good Fat Conversion Could Lead…
News
Ground Control to Major Microbe: New Method IDs Bacteria in Space
Insights
NIH Solicits Research into Vaccines to Protect against Opioid Use
Magazine
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
May 2019 Vol. 39 No. 5
Genomics’ “Green” Future
May 2019 Vol. 39 No. 5
Crafting a More Efficient CAR T-Cell Industry
May 2019 Vol. 39 No. 5
All About That Base Editing
May 2019 Vol. 39 No. 5
Signs, Portents, and Immuno-Oncology Biomarkers
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Podcasts
GENcast: Explore, Learn, and Collaborate on Viral Safety in Biomanufacturing
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
Upcoming Webinars
Recent Advances and the Future of Antibody Engineering
Videos
3D Bioprinted Organ Just Took Its First “Breath”
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Cancer
Gastric Cancer
Gastric Cancer
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Gastric Cancer
AstraZeneca, Daiichi Sankyo Launch Potentially $6.9B+ Collaboration to Develop Cancer ADC
Gastric Cancer
Redx Halts Enrollment in Trial of Lead Candidate, Citing Adverse Events
Gastric Cancer
Janssen to Develop Bispecific Antibodies Based on Zymeworks Platforms in Up-to-$1.4B Deal
Gastric Cancer
Sumitomo Dainippon Cancer Stemness Inhibitor Napabucasin Disappoints in Phase III
Gastric Cancer
Roche’s Kadcyla Fails Phase II/III Trial for Gastric Cancer
Gastric Cancer
Adhesin Structure Shows How H. pylori Hangs on for Dear Life
Gastric Cancer
Amgen Halts Rilotumumab Trials in Advanced Gastric Cancer
Gastric Cancer
BMS Signs Up to $475M Option to Acquire F-star’s FS102
Gastric Cancer
Roche Cancer Vaccine Pact Could Net Immatics $1B-Plus
Gastric Cancer
Lilly Peers Into Future, Sees Three Drug Launches in 2014
Gastric Cancer
Epigenetics Study Identifies Gastric Cancer Subtype
Gastric Cancer
EC Approves Three-Year Treatment Label Update for Novartis’ Glivec
Gastric Cancer
FDA Approves Label Change Recommending Three Years of Novartis’ Glivec After...
Gastric Cancer
BMS and Aslan Establish Deal for Early Clinical-Stage Anticancer cMET Inhibitor
Gastric Cancer
Aslan Pharmaceuticals Licenses Array’s Phase II-Stage Solid Tumor Candidate
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Array will initiate proof-of-concept program in Asia for ARRY-543 against gastric cancer.[© picsfive - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/July13_2011_10745288_TumorXray_ArrayLicensesCancerDrugtoAslan2321637198-324x160.jpg "Aslan Pharmaceuticals Licenses Array’s Phase II-Stage Solid Tumor Candidate")
